Green, AI, Patel, JK, Goisman, RM, Allison, DB, Blackburn, G. Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psychiatry
2000; 22: 224–35.
Álvarez-Jiménez, M, González-Blanch, C, Crespo-Facorro, B, Hetrick, S, Rodriguez-Sanchez, JM, Perez-Iglesias, R, Vázquez-Barquero, JL. Antipsychotic–induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs
Zipursky, RB, Gu, H, Green, AI, Perkins, DO, Tohen, MF, McEvoy, JP, Strakowski, SM, Sharma, T, Kahn, RS, Gur, RE, Tollefson, GD, Lieberman, JA. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry
2005; 187: 537–43.
Wirshing, DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry
2004; 65 (suppl 18): s13–26.
Faulkner, G, Cohn, T, Remington, G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev
2007; (1): CD005148.
Deeks, JJ, Altman, DG, Bradburn, MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-Analysis in Context (eds Egger, M, Smith, GD & Altman, D): 285–312. Wiley Blackwell, 2001.
Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ
2003; 327: 557–60.
DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials
1986; 7: 177–88.
Egger, M, Smith, GD, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–34.
Light, RJ, Pillemer, DB. Summing Up: The Science of Reviewing Research: 13–31. Harvard University Press, 1984.
Egger, M, Smith, GD, Phillips, AN. Meta-analysis. Principles and procedures. BMJ
1997; 315: 1533–7.
Centorrino, F, Wurtman, JJ, Duca, KA, Fellman, VH, Fogarty, KV, Berry, JM, Guay, DM, Romeling, M, Kidwell, J, Cincotta, SL, Baldessarini, RJ. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes
2006; 30: 1011–6.
Feeney, L, Dempsey, J, Moynihan, F, Barry, S. Changes in body mass indices of patients with schizophrenia 3 years following the introduction of a weight management programme. Ir Med J
2003; 96: 276–7.
Kalarchian, MA, Marcus, MD, Levine, MD, Haas, GL, Greeno, CG, Weissfeld, LA, Qin, L. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry
2005; 66: 1058–63.
Klein, B, Simon, WE, Steele, RL, Primavera, LH. Reinforcement and weight loss in schizophrenics. Psychol Rep
1972; 30: 581–2.
Knox, JM. A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry
1980; 136: 287–9.
Ball, MP, Coons, VB, Buchanan, RW. A program for treating olanzapine-related weight gain. Psychiatr Serv
2001; 52: 967–9.
McCreadie, R, Macdonald, E, Blacklock, C, Tilak-Singh, D, Wiles, D, Halliday, J, Paterson, J. Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. BMJ
1998; 317: 784–5.
Menza, M, Vreeland, B, Minsky, S, Gara, M, Radler, DR, Sakowitz, M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry
2004; 65: 471–7.
Sletten, I, Mou, B, Cazenave, M, Gershon, S. Effects of caloric restriction on behaviour and body weight during chloropromazine therapy
Dis Nerv Syst
1967; 28: 519–22.
Voruganti, LN, Whatham, J, Bard, E, Parker, G, Babbey, C, Ryan, J, Lee, S, MacCrimmon, DJ. Going beyond. An adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia. Can J Psychiatry
2006; 51: 575–80.
Vreeland, B, Minsky, S, Menza, M, Rigassio Radler, D, Roemheld-Hamm, B, Stern, R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv
2003; 54: 1155–7.
Harmatz, MG, Lapuc, P. Behavior modification of overeating in a psychiatric population. J Consult Clin Psychol
1968; 32: 583–7.
Rotatori, AF, Fox, R, Wicks, A. Weight loss with psychiatric residents in a behavioral self control program. Psychol Rep
1980; 46: 483–6.
Brown, C, Goetz, J, Van Sciver, A, Sullivan, D, Hamera, E. A psychiatric rehabilitation approach to weight loss. Psychiatr Rehabil J
2006; 29: 267–73.
Archie, S, Wilson, JH, Osborne, S, Hobbs, H, McNiven, J. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry
2003; 48: 628–32.
McCreadie, RG, Kelly, C, Connolly, M, Williams, S, Baxter, G, Lean, M, Paterson, JR. Dietary improvement in people with schizophrenia. Randomised controlled trial. Br J Psychiatry
2005; 187: 346–51.
Beebe, LH, Tian, L, Morris, N, Goodwin, A, Allen, SS, Kuldau, J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs
2005; 26: 661–76.
Álvarez-Jiménez, M, González-Blanch, C, Vázquez-Barquero, JL, Pérez-Iglesias, R, Martínez-García, O, Pérez-Pardal, T, Ramírez-Bonilla, ML, Crespo-Facorro, B. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients. A randomized controlled trial. J Clin Psychiatry
2006; 67: 1253–60.
Brar, JS, Ganguli, R, Pandina, G, Turkoz, I, Berry, S, Mahmoud, R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry
2005; 66: 205–12.
Khazaal, Y, Fresard, E, Rabia, S, Chatton, A, Rothen, S, Pomini, V, Grasset, F, Borgeat, F, Zullino, D. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res
2007; 91: 169–77.
Kwon, JS, Choi, JS, Bahk, WM, Yoon Kim, C, Hyung Kim, C., Chul Shin, Y, Park, BJ, Geun Oh, C. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder. A 12-week randomized controlled clinical trial. J Clin Psychiatry
2006; 67: 547–53.
McKibbin, CL, Patterson, TL, Norman, G, Patrick, K, Jin, H, Roesch, S, Mudaliar, S, Barrio, C, O'Hanlon, K, Griver, K, Sirkin, A, Jeste, DV. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res
2006; 86: 36–44.
Weber, M, Wyne, K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res
2006; 83: 95–101.
Evans, S, Newton, R, Higgins, S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry
2005; 39: 479–86.
Littrell, KH, Hilligoss, NM, Kirshner, CD, Petty, RG, Johnson, CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh
2003; 35: 237–41.
Scocco, P, Longo, R, Caon, F. Weight change in treatment with olanzapine and a psychoeducational approach. Eat Behav
2006; 7: 115–24.
Wu, MK, Wang, CK, Bai, YM, Huang, CY, Lee, SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv
2007; 58: 544–50.
Pendlebury, J, Bushe, CJ, Wildgust, HJ, Holt, RIG. Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand
2007; 115: 286–94.
Haddock, G, Lewis, S, Bentall, R, Dunn, G, Drake, R, Tarrier, N. Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatry
2006; 188: 250–4.
Coldham, EL, Addington, J, Addington, D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand
2002; 106: 286–90.
Gortmaker, SL, Must, A, Perrin, JM, Sobol, AM, Dietz, WH. Social and economic consequences of overweight in adolescence and young adulthood
N Engl J Med
1993; 329: 1008–12.
McGorry, PD, Hickie, IB, Yung, AR, Pantelis, C, Jackson, HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry
2006; 40: 616–22.
Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs.
National Academy Press, 1995.
Marder, SR, Essock, SM, Miller, AL, Buchanan, RW, Casey, DE, Davis, JM, Kane, JM, Lieberman, JA, Schooler, NR, Covell, N, Stroup, S, Weissman, EM, Wirshing, DA, Hall, CS, Pogach, L, Pi-Sunyer, X, Bigger, JT Jr, Friedman, A, Kleinberg, D, Yevich, SJ, Davis, B, Shon, S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry
2004; 161: 1334–49.
Juni, P, Altman, DG, Egger, M. Systematic reviews in health care. Assessing the quality of controlled clinical trials. BMJ
2001; 323: 42–6.
Bradshaw, T, Lovell, K, Harris, N. Healthy living interventions and schizophrenia: a systematic review. J Adv Nurs
2005; 49: 634–54.
Weiden, PJ, Mackell, JA, McDonnell, DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res
2004; 66: 51–7.
Allison, DB, Mackell, JA, McDonnell, DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv
2003; 54: 565–7.
Aronne, LJ. Epidemiology, morbidity, and treatment of overweight and obesity. J Clin Psychiatry
2001; 62 (suppl 23): s13–22.
Crisp, AH, Gelder, MG, Rix, S, Meltzer, HI, Rowlands, OJ. Stigmatisation of people with mental illnesses. Br J Psychiatry
2000; 177: 4–7.